FDA Coronavirus (COVID-19) Update for April 2nd, 2020

Silver Spring, MD – On Thursday, April 2nd, 2020, the U.S. Food and Drug Administration (FDA) announced the following actions taken in its ongoing response effort to the Coronavirus (COVID-19) pandemic:

The FDA announced that it is revising recommendations in several guidances regarding blood donor eligibility. These changes are based on recently completed studies and epidemiological data, leading the FDA to conclude that the polices could be modified without compromising the safety of the blood supply.

[Read more]